A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Itamar Medical Selected to Participate in the Prestigious Weizmann Institute Project 10K

Itamar Medical Ltd.develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market.  Today they announced that its WatchPAT has been selected for inclusion in the Weizmann Institute’s Project 10K.

One of the largest projects of its kind, the 10K Project is a longitudinal study designed to collect lifestyle and clinical data from 10,000 individuals over ten years and aims to use state-of-the-art artificial intelligence technologies to analyze the data in order to generate personalized predictions for disease risk factors. These predictions may improve health outcomes by enabling detection and intervention of treatable medical conditions prior to the onset of symptoms.

“The choice of Itamar Medical’s advanced WatchPAT system for the diagnosis of sleep apnea emphasizes the relationship and significance that the medical and public health communities attribute to the sleep dimension and the impact of sleep quality on the risks of morbidity and heart disease in particular,” said Gilad Glick, President and Chief Executive Officer of Itamar Medical. “We are pleased to be part of Project 10K and to help expand the understanding of the role that sleep apnea plays in multiple aspects of human health.”

As part of the project, Itamar will provide 150,000 WatchPAT tests for the diagnosis and monitoring of sleep apnea. Each subject will undergo a WatchPAT Sleep Apnea diagnostic test once every two years. The WatchPAT’s signals and test results will be used by the team of researchers in developing advanced artificial intelligence-based prediction tools that will reveal connections between sleep apnea and other health conditions that have not previously been known or understood.

Prof. Eran Segal, who is leading Project 10K, said, “WatchPAT’s ability to monitor sleep so comprehensively in combination with the multitude of other parameters we are collecting from individuals participating in the project will allow us to find unprecedented new connections between sleep and morbidity.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy